398 related articles for article (PubMed ID: 16920826)
1. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
Dang Y; Wang X; Esselman WJ; Zheng YH
J Virol; 2006 Nov; 80(21):10522-33. PubMed ID: 16920826
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
Yu Q; Chen D; König R; Mariani R; Unutmaz D; Landau NR
J Biol Chem; 2004 Dec; 279(51):53379-86. PubMed ID: 15466872
[TBL] [Abstract][Full Text] [Related]
3. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
Romani B; Engelbrecht S; Glashoff RH
Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.
Smith JL; Pathak VK
J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965
[TBL] [Abstract][Full Text] [Related]
5. Further investigation of simian immunodeficiency virus Vif function in human cells.
Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; Beer BE; Marx PA; Gao F; Bibollet-Ruche F; Hahn BH; Malim MH
J Virol; 2004 Nov; 78(21):12041-6. PubMed ID: 15479843
[TBL] [Abstract][Full Text] [Related]
6. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
Chaipan C; Smith JL; Hu WS; Pathak VK
J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
[TBL] [Abstract][Full Text] [Related]
10. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B; Yu X; Luo K; Yu Y; Yu XF
J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral defense by APOBEC3 family proteins].
Takaori A
Uirusu; 2005 Dec; 55(2):267-72. PubMed ID: 16557012
[TBL] [Abstract][Full Text] [Related]
12. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
13. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
[TBL] [Abstract][Full Text] [Related]
14. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms for inhibition of retrovirus replication by APOBEC3 family].
Iwatani Y
Uirusu; 2011 Jun; 61(1):67-72. PubMed ID: 21972557
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
17. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
Zhou T; Han Y; Dang Y; Wang X; Zheng YH
Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
Zennou V; Bieniasz PD
Virology; 2006 May; 349(1):31-40. PubMed ID: 16460778
[TBL] [Abstract][Full Text] [Related]
19. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
20. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]